Intellectual Property & Protected Innovation
BioDrop follows an IP-first development strategy. Material technical advances are evaluated for patent protection before publication, public presentation, or disclosure to external development partners.
Additional intellectual-property development is underway in areas including multi-omics analysis, disease-specific biomarker applications, and computational interpretation.
Patent applications are subject to examination, amendment, grant, refusal or withdrawal. A pending application does not constitute a granted patent.
